• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number RED72SDKIT
Device Problems Fracture (1260); Physical Resistance/Sticking (4012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/28/2023
Event Type  malfunction  
Manufacturer Narrative
Evaluation of the returned red72 confirmed a fracture on the distal shaft.Evaluation revealed stretching on both sides of the fracture.The distal fractured segment was ovalized and kinked.This indicates the distal portion of the red72 may have become pinned at some point during retraction.If the red72 is subsequently retracted against resistance, the device may become stretched and fracture.Some of the kinks on the distal fractured segment may have been due to snaring during the procedure.The sendit was unable to be retracted from the red72, and therefore, could not to be functionally tested.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Event Description
The patient was undergoing a thrombectomy procedure in the left m1 segment of the middle cerebral artery (mca) using a penumbra system red 72 reperfusion catheter (red72), a sendit delivery device (sendit), a bmx96 access system (bmx96), and a non-penumbra guide catheter.It was reported the patient¿s anatomy was tortuous.During the procedure, the physician advanced the red72 and sendit to the target location and completed one pass.It was reported that the pass resulted in thrombolysis in cerebral infarction (tici) grade 2b.During the next pass, the physician experienced resistance and subsequently, the red72 fractured.The physician then removed the red72 against resistance.Upon removal, approximately twenty centimeters of the distal portion of the red72 was missing and remained in the internal carotid artery (ica).The physician then used a snare device and removed the remaining portion of the red72 from the patient¿s body.The procedure was completed using a new red72, a penumbra system red 43 reperfusion catheter (red43), the same sheath, and a non-penumbra microwire resulting in thrombolysis in cerebral infarction (tici) grade 3.There was no report of an adverse effect to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key17989117
MDR Text Key327358822
Report Number3005168196-2023-00476
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00815948025943
UDI-Public815948025943
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K211654
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/01/2005,10/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRED72SDKIT
Device Lot NumberF00006942
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/04/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 09/28/2023
Initial Date FDA Received10/23/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/31/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age85 YR
Patient SexFemale
-
-